ES2054715T3 - Nuevos derivados de naftaleno y productos farmaceuticos antialergicos y antiinflamatorios. - Google Patents

Nuevos derivados de naftaleno y productos farmaceuticos antialergicos y antiinflamatorios.

Info

Publication number
ES2054715T3
ES2054715T3 ES88102487T ES88102487T ES2054715T3 ES 2054715 T3 ES2054715 T3 ES 2054715T3 ES 88102487 T ES88102487 T ES 88102487T ES 88102487 T ES88102487 T ES 88102487T ES 2054715 T3 ES2054715 T3 ES 2054715T3
Authority
ES
Spain
Prior art keywords
naftalene
allergic
pharmaceutical products
new derivatives
inflammatory pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES88102487T
Other languages
English (en)
Inventor
David Thomas Connor
Paul Charles Unangst
Robert James Weikert
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Warner Lambert Co LLC
Original Assignee
Warner Lambert Co LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co LLC filed Critical Warner Lambert Co LLC
Application granted granted Critical
Publication of ES2054715T3 publication Critical patent/ES2054715T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04—Five-membered rings
    • C07D257/06—Five-membered rings with nitrogen atoms directly attached to the ring carbon atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Peptides Or Proteins (AREA)
  • Pyrrole Compounds (AREA)

Abstract

NUEVOS DERIVADOS DE NAFTALENO DE LA FORMULA (I) QUE TIENEN ACTIVIDAD ANTIALERGICA Y ANTIINFLAMATORIA.
ES88102487T 1987-02-20 1988-02-19 Nuevos derivados de naftaleno y productos farmaceuticos antialergicos y antiinflamatorios. Expired - Lifetime ES2054715T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/016,811 US4767776A (en) 1987-02-20 1987-02-20 N-1H-tetrazol-5-yl-2-naphthalene carboxamides and their use as antiallergy and antiinflammatory agents

Publications (1)

Publication Number Publication Date
ES2054715T3 true ES2054715T3 (es) 1994-08-16

Family

ID=21779114

Family Applications (1)

Application Number Title Priority Date Filing Date
ES88102487T Expired - Lifetime ES2054715T3 (es) 1987-02-20 1988-02-19 Nuevos derivados de naftaleno y productos farmaceuticos antialergicos y antiinflamatorios.

Country Status (16)

Country Link
US (1) US4767776A (es)
EP (1) EP0279466B1 (es)
JP (1) JPS63222161A (es)
KR (1) KR880009948A (es)
AT (1) ATE89556T1 (es)
AU (1) AU596054B2 (es)
DE (1) DE3881073T2 (es)
DK (1) DK84088A (es)
ES (1) ES2054715T3 (es)
FI (1) FI880748A7 (es)
IE (1) IE61482B1 (es)
NO (1) NO880731L (es)
NZ (1) NZ223477A (es)
PH (1) PH24687A (es)
PT (1) PT86785B (es)
ZA (1) ZA88385B (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5257726A (en) * 1985-08-14 1993-11-02 Ing. Erich Pfeiffer Gmbh & Co. Kg Dispenser for flowable media
US5073566A (en) * 1989-11-30 1991-12-17 Eli Lilly And Company Angiotensin ii antagonist 1,3-imidazoles and use thereas
US5434188A (en) * 1994-03-07 1995-07-18 Warner-Lambert Company 1-ether and 1-thioether-naphthalene-2-carboxamides as inhibitors of cell adhesion and as inhibitors of the activation of HIV
AU2002322720B2 (en) 2001-07-25 2008-11-13 Raptor Pharmaceutical Inc. Compositions and methods for modulating blood-brain barrier transport
GB2405146A (en) * 2002-06-07 2005-02-23 Cortical Pty Ltd Napthalene derivatives which inhibit the cytokine or biological activity of macrophage migration inhibitory factor (MIF)
BRPI0410940A (pt) * 2003-06-05 2006-08-29 Warner Lambert Co benzo[b]tiofenos substituìdos com cicloalquilsulfanila como agentes terapêuticos
CA2527934A1 (en) * 2003-06-05 2004-12-16 Warner-Lambert Company Llc Tetrazol benzofurancarboxamides with p13k activity as therapeutic agents
US20040259926A1 (en) * 2003-06-05 2004-12-23 Bruendl Michelle M. 3-Aryloxy and 3-heteroaryloxy substituted benzo[b]thiophenes as therapeutic agents
CA2527573A1 (en) * 2003-06-05 2004-12-16 Warner-Lambert Company Llc Cycloalkyl and heterocycloalkyl substituted benzothiophenes as therapeutic agents
WO2004108716A1 (en) * 2003-06-05 2004-12-16 Warner-Lambert Company Llc 3-arylsulfanyl and 3-heteroarylsulfanyl substituted benzo[b]thiophenes as therapeutic agents
EP1644360A1 (en) * 2003-06-05 2006-04-12 Warner-Lambert Company LLC 3-substituted indoles and derivatives thereof as therapeutic agents
US7318709B2 (en) * 2003-08-27 2008-01-15 Haldex Brake Corporation Pump valve assembly
CA2789262C (en) 2005-04-28 2016-10-04 Proteus Digital Health, Inc. Pharma-informatics system
EP2063905B1 (en) 2006-09-18 2014-07-30 Raptor Pharmaceutical Inc Treatment of liver disorders by administration of receptor-associated protein (rap)-conjugates
TR201908314T4 (tr) 2009-02-20 2019-06-21 2 Bbb Medicines B V Glutatyon bazlı ilaç dağıtım sistemi.
KR101909711B1 (ko) 2009-05-06 2018-12-19 라보라토리 스킨 케어, 인크. 활성제-칼슘 포스페이트 입자 복합체를 포함하는 피부 전달 조성물 및 이들을 이용하는 방법
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates
ES2659553T3 (es) * 2011-12-21 2018-03-16 Syngenta Limited Compuestos herbicidas
BR112014026823A2 (pt) * 2012-04-27 2017-06-27 Basf Se compostos de n-(tetrazol-5-il) e n-(triazol-5-il)arilcarboxamida substituída e seu uso como herbicidas.
WO2014184073A1 (en) * 2013-05-15 2014-11-20 Basf Se Substituted n-(tetrazol-5-yl)- and n-(triazol-5-yl)arylcarboxamide compounds and their use as herbicides

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1343827A (en) * 1971-06-15 1974-01-16 Science Union & Cie Acylaminotetrazoles and process for preparing them
BE789822A (fr) * 1971-10-08 1973-04-06 Allen & Hanburys Ltd Nouveaux composes heterocycliques
US4145350A (en) * 1972-09-06 1979-03-20 Burroughs Wellcome Co. Cyclic sulphur compounds triazolyl substituted phenoxathin 10, 10 dioxides
GB1561350A (en) * 1976-11-05 1980-02-20 May & Baker Ltd Benzamide derivatives
US4147694A (en) * 1977-02-07 1979-04-03 Riker Laboratories, Inc. 8-(1H-Tetrazol-5-yl-carbamoyl)quinoline compounds
US4432986A (en) * 1979-06-18 1984-02-21 Riker Laboratories, Inc. Tetrazoles bonded to certain polycyclic aromatic systems and anti-allergic use thereof
US4474792A (en) * 1979-06-18 1984-10-02 Riker Laboratories, Inc. N-Tetrazolyl benzamides and anti-allergic use thereof

Also Published As

Publication number Publication date
EP0279466A3 (en) 1989-08-02
AU1111988A (en) 1988-09-01
NO880731L (no) 1988-08-22
IE61482B1 (en) 1994-11-02
PH24687A (en) 1990-09-07
EP0279466B1 (en) 1993-05-19
DK84088D0 (da) 1988-02-18
EP0279466A2 (en) 1988-08-24
PT86785A (pt) 1988-03-01
FI880748A0 (fi) 1988-02-17
DE3881073T2 (de) 1993-09-02
DE3881073D1 (de) 1993-06-24
KR880009948A (ko) 1988-10-06
NZ223477A (en) 1990-01-29
US4767776A (en) 1988-08-30
PT86785B (pt) 1992-05-29
JPS63222161A (ja) 1988-09-16
FI880748A7 (fi) 1988-08-21
IE880125L (en) 1988-08-20
DK84088A (da) 1988-08-21
AU596054B2 (en) 1990-04-12
NO880731D0 (no) 1988-02-19
ZA88385B (en) 1989-09-27
ATE89556T1 (de) 1993-06-15

Similar Documents

Publication Publication Date Title
ES2054715T3 (es) Nuevos derivados de naftaleno y productos farmaceuticos antialergicos y antiinflamatorios.
DE3776946D1 (de) Nasale verabreichung von arzneimitteln.
MX9202851A (es) Derivados de fosfato de los glucosidos de 4-desmetilepipodofilotoxina y composicion farmaceutica que los contiene.
ATE74003T1 (de) Waessriges pharmazeutisches praeparat.
MX9203126A (es) Derivados de sulfonilurea y composiciones farmaceuticas que los contienen.
ES2102475T3 (es) Nuevas alquil-amidas heterociclicas, su procedimiento de preparacion y composiciones farmaceuticas que las contienen.
FR2415616A1 (fr) Derives d'acides phenylacetiques et medicaments qui en contiennent
NL970023I1 (nl) Medicamenten voor behandeling van oogontsteking.
ES2102144T3 (es) Nuevos derivados de estradieno de 11-benzaldoxima-17beta metoxi-17alfa-metoximetilo un procedimiento para su produccion y productos medicinales que contienen estos compuestos.
FR2433512A1 (fr) Derives de l'indane et medicaments qui en contiennent
IT8847871A0 (it) Ne e loro impiego come medicamenti derivati peptidici,loro preparazio-
DE3866737D1 (de) Bisphosphonsaeure-derivate und sie enthaltende arzneimittel.
ES2045484T3 (es) Nuevos derivados de la vitamina d: aplicaciones terapeuticas y a las dosificaciones de los metabolitos de la vitamina d.
PT87024A (pt) Process for the preparation of propiolophenone derivatives and of pharmaceutical compositions containing the same
IT8721691A0 (it) Derivati dell'ossima della 1,2,5,6-tetraidropirdin-3-carbossaldeide, loro procedimento di preparazione e loro impiegocome sostanze medicinali.
IT1227576B (it) Ciclodestrinclatrati di derivati della 5-ciano-prostaciclina e loro impiego come medicinali
ES2043943T3 (es) Procedimiento para la preparacion de compuestos con actividad analgesica central.
ES2118248T3 (es) Esteres y amidas de 9-cloro-prostaglandina y su empleo para preparar medicamentos.
IT8723280A0 (it) Derivati della 3 piperidinocarbaldeide ossima, loro procedimento di preparazione e loro applicazione come farmaci
IT8449056A0 (it) Derivati dell'1,2-ditiolano,loro preparazione e loro impiego come medicamenti
FI891210A7 (fi) Tiosulfiinihappojohdannaiset, niiden käyttö tulehdussairauksien käsitt elyyn sekä näitä aineita sisältävät lääkeaineet
IT1105534B (it) Derivati di alfa-alogenometilammino acidi ad attivita' farmaceutica e procedimento per la loro preparazione
IT8322486A0 (it) N-acetilcisteina ederivati 2',4's-carbossimetilcisteina ad-difluoro-4-idrossi-(1,1'-bifenil)attivita' antinfiammatoria, 3-carbossilici della mucolitica, procedimento per laloro preparazione e relative composizioni farmaceutiche.
PT86933A (pt) Process for the preparation pf optically active oxo-isoindolinyul derivatives and of pharmaceutical compositions containing the same
FI871479A0 (fi) Menetelmä lääkeaineina käyttökelpoisten perhydrotiatsepiini- ja perhydroatsepiinijohdannaisten valmistamiseksi

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 279466

Country of ref document: ES